Skip to content

Tumour Sites
- Breast
- GI
- GU
- Gynecology
- Hematology
- Lung
- Melanoma
- Sarcoma
- Other Topics
Events
Podcast
Career Hub
- View Openings
- Post A Job
About Us
My Account
Search

Tumour Sites
- Breast
- GI
- GU
- Gynecology
- Hematology
- Lung
- Melanoma
- Sarcoma
- Other Topics
Events
Podcast
Career Hub
- View Openings
- Post A Job
About Us
My Account
Search

Login
Register
My Account
- Edit Profile
search

Login
Register
My Account
- Edit Profile
search

Search for:

Podium to Practice: ASH® 2025

Podium to Practice: ASH® 2025

Podium to Practice ASH 2025 RT LP

Videos

LEUKEMIA

Dr. Jorge Cortes (Chair)

Dr. Jorge Cortes

Dr. Lynn Savoie

Dr. Lynn Savoie

Dr. Brian Leber

Dr. Brian Leber

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: PARADIGM

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: Phase II Trial of Venetoclax Regimens vs. Intensive Chemotherapy in Older AML

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: VICEROY Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: AUGMENT-101 Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: KOMET-007

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: GIMEMA ALL2820

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: graall-2014/b-QUEST Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: Venetoclax + Inotuzumab in R/R ALL: Phase I Results

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: ASC4FIRST Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: ASC2ESCALATE Trial

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: CARDINAL

LYMPHOMA

Dr. Carolyn Owen (Chair)

Dr. Carolyn Owen

Dr. Anca Prica

Dr. Kerry Savage

Dr. Kerry Savage

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Results from the randomized CLL17 Trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: First Phase III Comparison of Non-Covalent vs. Covalent BTKi in CLL/SLL

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Epcore FL-1 Trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: 5 years of follow-up from the Phase 1/2 BRUIN study

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: 3-year follow-up of the S1826 study

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Final analysis of the Phase III GHSG HD21 trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Real-World Pola-R-CHP Outcomes in Frail Older Adults with DLBCL

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Results from EPCORE DLBCL-3

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: A real-world study from the DESCAR-T registry

MULTIPLE MYELOMA

Dr. Donna Reece (Chair)

Dr. Donna Reece

Dr. Darrell White

Dr. Darrell White

Dr. Maria-Victoria Mateos

Dr. Maria Victoria Mateos Manteca

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Early DPd Rescue in High-Risk Smoldering Myeloma Post-KRd-ASCT: GEM-CESAR Study

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Daratumumab vs Observation in High-Risk SMM: AQUILA Outcomes by Risk and Age

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: AURIGA Study

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: RADAR trial in newly diagnosed transplant eligible patients

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: TecLILLE trial, cohort a

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Phase 1b of REDIRECTT-1: Results with an extended median follow-up of 3 years

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Increased teclistamab dosing interval improves T-cell diversity and reduces infection risk

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Results of MajesTEC-3

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Optimizing Safety of Cilta-Cel in Relapsed MM: Modifiable Risk Factors for Delayed Neurotoxicity and NRM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Predictors of Early Relapse After Cilta-Cel in R/R MM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Long-Term PFS Benefit of Cilta-Cel in Standard-Risk R/R MM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Updated results from iMMagine–1

Podcasts

LEUKEMIA

Dr. Jorge Cortes (Chair)

Dr. Jorge Cortes

Dr. Lynn Savoie

Dr. Lynn Savoie

Dr. Brian Leber

Dr. Brian Leber

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: PARADIGM

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: Phase II Trial of Venetoclax Regimens vs. Intensive Chemotherapy in Older AML

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: VICEROY Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: AUGMENT-101 Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: KOMET-007

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: GIMEMA ALL2820

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: graall-2014/b-QUEST Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: Venetoclax + Inotuzumab in R/R ALL: Phase I Results

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: ASC4FIRST Study

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: ASC2ESCALATE Trial

2025

Podium to Practice: ASH® 2025 – LEUKEMIA: CARDINAL

LYMPHOMA

Dr. Carolyn Owen (Chair)

Dr. Carolyn Owen

Dr. Anca Prica

Dr. Kerry Savage

Dr. Kerry Savage

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Results from the randomized CLL17 Trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: First Phase III Comparison of Non-Covalent vs. Covalent BTKi in CLL/SLL

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Epcore FL-1 Trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: 5 years of follow-up from the Phase 1/2 BRUIN study

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: 3-year follow-up of the S1826 study

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Final analysis of the Phase III GHSG HD21 trial

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Real-World Pola-R-CHP Outcomes in Frail Older Adults with DLBCL

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: Results from EPCORE DLBCL-3

2025

Podium to Practice: ASH® 2025 – LYMPHOMA: A real-world study from the DESCAR-T registry

MULTIPLE MYELOMA

Dr. Donna Reece (Chair)

Dr. Donna Reece

Dr. Darrell White

Dr. Darrell White

Dr. Maria-Victoria Mateos

Dr. Maria Victoria Mateos Manteca

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Early DPd Rescue in High-Risk Smoldering Myeloma Post-KRd-ASCT: GEM-CESAR Study

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Daratumumab vs Observation in High-Risk SMM: AQUILA Outcomes by Risk and Age

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: AURIGA Study

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: RADAR trial in newly diagnosed transplant eligible patients

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: TecLILLE trial, cohort a

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Phase 1b of REDIRECTT-1: Results with an extended median follow-up of 3 years

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Increased teclistamab dosing interval improves T-cell diversity and reduces infection risk

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Results of MajesTEC-3

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Optimizing Safety of Cilta-Cel in Relapsed MM: Modifiable Risk Factors for Delayed Neurotoxicity and NRM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Predictors of Early Relapse After Cilta-Cel in R/R MM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Long-Term PFS Benefit of Cilta-Cel in Standard-Risk R/R MM

2025

Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: Updated results from iMMagine–1

To Top

Tagged page-parent-for-videos-or-podcasts unlisted

© All rights reserved

Made with ❤ by Elementor

Oncology Career Hub
Post A Job
Scientific Steering Committee
Events
Podcast

About Us
Contact Us
Terms of Use
Disclaimer
MDBriefCase
RxBriefCase

199 Bay Street #4000
Toronto, ON M5L 1A9

©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.

Twitter Instagram Facebook-f Linkedin-in

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Tumour Sites
- Breast
- Colorectal
- GI
- GU
- Gynecology
- Hematology
- Lung
- Melanoma
- Sarcoma
- Other Topics
Events
Oncology Career Hub
- View Openings
- Post A Job
About Us

Login
Register

Search for:

Pre-Video Survey

By continuing to watch the video, you consent to receiving a post-view survey by email.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. See our privacy policy and cookie policy.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled